Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives (Q40840690)

24 September 2017

Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives (English)

1 reference

24 September 2017

0 references

Axon AT

1

1 reference

PMC publication ID

1766606

24 September 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

24 September 2017

1 reference

24 September 2017

43 Suppl 1

1 reference

24 September 2017

S70-3

1 reference

Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

The complete genome sequence of the gastric pathogen Helicobacter pylori

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766606

One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9764045

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9764045

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Frontiers in Helicobacter pylori research: pathogenesis, host response, vaccine development and new therapeutic approaches

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9764045

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.43.2008.S70

1 reference

24 September 2017

1 reference

PMC publication ID

1766606

24 September 2017

PubMed publication ID

9764045

1 reference

PMC publication ID

1766606